Metoprolol Tartrate Market
- 2026 年市場規模
- USD 2.5 Bn
- 2033 年預估規模
- USD 4.0 Bn
- 年複合成長率 CAGR
- 8.7%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Metoprolol Tartrate Market, By Route Of Administration (Oral, Injectable), By Application (Hypertension, Cardiovascular, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
Metoprolol Tartrate is a selective β1 receptor blocker medication that is designed for the treatment of cardiovascular diseases and hypertension, as it works as slowing down the heart rate and makes the heart more efficient at pumping blood around the body. It is used for treating high blood pressure issues, chest pain due to low blood circulation to the heart, and abnormal heart rate. Metoprolol Tartrate is mostly used in the treatment of Angina pectoris, Cardiac arrhythmias, and thyrotoxicosis. Metoprolol Tartrate is available in two types of formulations including oral and injectable. The generic form of Metoprolol Tartrate is Lopressor. Metoprolol comes in form of immediate-release tablets which are designed to disintegrate and release medicine and extended-release tablets and it is prescribed medicine only.
Market Dynamics
Increasing prevalence of cardiovascular diseases in various region is expected to drive the global metoprolol tartrate market over the forecast period. For instance, in August 2021, European statistics published data on cardiovascular diseases, stating that in the year 2019, approximately 45,400 bypass surgeries were conducted in Germany. Moreover, in the year 2016, 1.68 million deaths occurred due to cardiovascular diseases in the Europe region. The same data on prevalence of cardiovascular diseases reported that high blood pressure increased in age group from 25 to 34 years and that around 3.4% of the population between this age group in Europe was reported to have hypertensive diseases. Furthermore, more than 54.6% population of hypertension diseases were aged 75 years or older, which is expected to drive demand for metoprolol tartrate in upcoming years.
Key features of the study
• This report provides an in-depth analysis of the global metoprolol tartrate market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global metoprolol tartrate market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
• Key companies covered as a part of this study include Novartis Pharmaceuticals Canada Inc., AstraZeneca Pharma India Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Inc., CTX Life Sciences Pvt. Ltd., Hikma Pharmaceuticals PLC, Validus Pharmaceuticals LLC, Alembic Pharmaceuticals Limited, Aurobindo Pharma USA, Sandoz Canada Inc., Apotex Inc., Ipca Laboratories Ltd, and Rubicon Research Pvt. Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global metoprolol tartrate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global metoprolol tartrate market.
Market Segmentation
• By Route of administration
o Oral
o Injectable
• By Application
o Hypertension
o Cardiovascular
o Others
• By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players
o Novartis Pharmaceuticals Canada Inc.
o AstraZeneca Pharma India Limited
o Teva Pharmaceutical Industries Ltd.
o Mylan N.V.
o Reddy’s Laboratories Ltd.
o Sun Pharmaceutical Industries Inc.
o CTX Life Sciences Pvt. Ltd.
o Hikma Pharmaceuticals PLC
o Validus Pharmaceuticals LLC
o Alembic Pharmaceuticals Limited
o Aurobindo Pharma USA
o Sandoz Canada Inc.
o Apotex Inc.
o Ipca Laboratories Ltd
o Rubicon Research Pvt. Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Route of Administration
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Global Metoprolol Tartrate Market, By Route of Administration, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
5. Global Metoprolol Tartrate Market, By Application, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Hypertension
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Cardiovascular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
6. Global Metoprolol Tartrate Market, By Distribution Channel, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2026 – 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2026–2033, (USD Bn)
7. Global Metoprolol Tartrate Market, By Region, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2026–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 – 2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 – 2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
Novartis Pharmaceuticals Canada Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
AstraZeneca Pharma India Limited
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Teva Pharmaceutical Industries Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Mylan N.V.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Dr. Reddy’s Laboratories Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Sun Pharmaceutical Industries Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
CTX Life Sciences Pvt. Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Hikma Pharmaceuticals PLC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Validus Pharmaceuticals LLC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Alembic Pharmaceuticals Limited
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Aurobindo Pharma USA
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Sandoz Canada Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Apotex Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Ipca Laboratories Ltd
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Rubicon Research Pvt. Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們